<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Results</title>
    <link rel="stylesheet" href="./lib/css/styles.css">
</head>
<body class="results">
<p><strong>Colorectal&nbsp; cancer&nbsp; screening.&nbsp; Average-risk&nbsp; individual.&nbsp; Age&nbsp; greater&nbsp; than&nbsp; or&nbsp; equal&nbsp; to&nbsp; 50&nbsp; years.&nbsp; Initial screening, then follow-up every 5 years after initial negative screen. </strong></p>
CT Colonography is usually  appropriate.<p/>
DCBE or MR may be appropriate.<p/>
SCBE is usually not appropriate.<p/>
<p><strong>CT colonography&nbsp; - CTC</strong></p>
<p>CTC&nbsp; (also&nbsp; known&nbsp; as&nbsp; &ldquo;virtual&nbsp; colonoscopy&rdquo;)&nbsp; was&nbsp; introduced&nbsp; in&nbsp; 1994&nbsp; as&nbsp; a&nbsp; less&nbsp; invasive&nbsp; method&nbsp; of&nbsp; imaging&nbsp; the&nbsp; colon&nbsp; by&nbsp; using&nbsp; helical&nbsp; CT.&nbsp; Similar&nbsp; to&nbsp; optical&nbsp; colonoscopy;&nbsp; patients&nbsp; undergo&nbsp; a&nbsp; preprocedural&nbsp; bowel&nbsp; cleansing&nbsp; preparation though with the addition of stool and fluid tagging agents. CTC is a considerably less invasive test as compared&nbsp; to&nbsp; optical&nbsp; colonoscopy,&nbsp; as&nbsp; reflected&nbsp; in&nbsp; the&nbsp; complication&nbsp; rate,&nbsp; in&nbsp; which&nbsp; the&nbsp; rate&nbsp; of&nbsp; perforation&nbsp; is&nbsp; 1&nbsp; in&nbsp; 22,000&nbsp; for&nbsp; CTC&nbsp; as&nbsp; opposed&nbsp; to&nbsp; 1&nbsp; in&nbsp; 1,000&nbsp; for&nbsp; diagnostic&nbsp; colonoscopy&nbsp; [38,39].&nbsp; The &nbsp;rectal&nbsp; tube&nbsp; is&nbsp; only&nbsp; inserted&nbsp; a&nbsp; short distance into the rectum to perform CTC, whereas the colonoscope traverses the entire length of the colon at colonoscopy. Additionally, CTC is performed without sedation, thus foregoing any complications associated with sedation. The&nbsp; American&nbsp; College&nbsp; of&nbsp; Radiology&nbsp; Imaging&nbsp; Network&nbsp; (ACRIN)&nbsp; National&nbsp; CTC&nbsp; Trial&nbsp; is&nbsp; the&nbsp; largest&nbsp; U.S.&nbsp; multicenter&nbsp; trial&nbsp; to&nbsp; date&nbsp; [40].&nbsp; Fifteen&nbsp; sites&nbsp; recruited&nbsp; a&nbsp; total&nbsp; of&nbsp; 2,531&nbsp; asymptomatic&nbsp; patients,&nbsp; who&nbsp; underwent&nbsp; multidetector-row CTC (16 rows or more) with stool and fluid tagging and mechanical carbon dioxide insufflation of the colon. All participating radiologists had to complete a qualifying examination, with a minimum accuracy of 90%&nbsp; for&nbsp; large&nbsp; polyps.&nbsp; Per-patient&nbsp; sensitivity,&nbsp; specificity,&nbsp; and&nbsp; positive&nbsp; and&nbsp; negative&nbsp; predictive&nbsp; values&nbsp; were&nbsp; 90%,&nbsp; 86%,&nbsp; 23%,&nbsp; and&nbsp; 99%,&nbsp; respectively,&nbsp; for&nbsp; detecting&nbsp; &ge;10-mm&nbsp; adenomas&nbsp; or&nbsp; cancers.&nbsp; The&nbsp; per-patient&nbsp; sensitivity&nbsp; for&nbsp; detecting&nbsp; adenomas&nbsp; &ge;6&nbsp; mm&nbsp; was&nbsp; 78%.&nbsp; The&nbsp; per-polyp&nbsp; sensitivity&nbsp; for&nbsp; &ge;10-mm&nbsp; adenomas&nbsp; or&nbsp; cancers&nbsp; was&nbsp; 84%.&nbsp; When comparing primary 2-D and primary 3-D interpretation methods, no difference in sensitivity was identified for the detection of large polyps. In another large study of 1,233 asymptomatic average-risk individuals undergoing colorectal cancer screening, the sensitivities of CTC and colonoscopy for detecting adenomatous polyps &ge;10 mm were 94% and 88%, respectively [41].&nbsp; A&nbsp; trial&nbsp; performed&nbsp; with&nbsp; 307&nbsp; asymptomatic&nbsp; subjects&nbsp; using&nbsp; 64&nbsp; multidetector-row&nbsp; CT&nbsp; demonstrated&nbsp; a&nbsp; CTC&nbsp; sensitivity and specificity of 91% and 93%, respectively, for polyps &ge;6 mm and 92% and 98%, respectively, for polyps &ge;10&nbsp; mm&nbsp; [42].&nbsp; Two&nbsp; meta-analyses&nbsp; of&nbsp; CTC&nbsp; performance&nbsp; in&nbsp; detecting&nbsp; &ge;10-mm&nbsp; polyps&nbsp; showed&nbsp; pooled&nbsp;</p>
<p>sensitivities by patient of 85% and 93%, with pooled specificities of 97% [43,44]. Some older studies have shown poorer&nbsp; performance&nbsp; of&nbsp; CTC&nbsp; (sensitivity&nbsp; of&nbsp; 55%&nbsp; to&nbsp; 59%)&nbsp; [45,46].&nbsp; These&nbsp; discrepant&nbsp; results&nbsp; were&nbsp; likely&nbsp; related&nbsp; to&nbsp; differences&nbsp; in&nbsp; study&nbsp; design,&nbsp; lack&nbsp; of&nbsp; reader&nbsp; training,&nbsp; and&nbsp; CTC&nbsp; technique&nbsp; (eg,&nbsp; no&nbsp; fecal&nbsp; tagging)&nbsp; in&nbsp; these&nbsp; older&nbsp; studies. The&nbsp; diagnostic&nbsp; yields&nbsp; of&nbsp; CTC&nbsp; and&nbsp; colonoscopy&nbsp; for&nbsp; advanced&nbsp; neoplasia&nbsp; have&nbsp; also&nbsp; been&nbsp; compared&nbsp; in&nbsp; parallel&nbsp; screening&nbsp; programs&nbsp; [47].&nbsp; Primary&nbsp; CTC&nbsp; screening&nbsp; in&nbsp; 3,120&nbsp; patients&nbsp; was&nbsp; compared&nbsp; with&nbsp; primary&nbsp; colonoscopy&nbsp; screening&nbsp; in&nbsp; 3,163&nbsp; subjects.&nbsp; Similar&nbsp; detection&nbsp; rates&nbsp; were&nbsp; found&nbsp; for&nbsp; CTC&nbsp; and&nbsp; colonoscopy&nbsp; screening,&nbsp; which&nbsp; identified 123 and 121 advanced neoplasms, respectively. The referral rate for colonoscopy in the CTC group was 8%. The total numbers of polyps removed in the CTC and colonoscopy groups were 561 and 2,434, respectively. Seven&nbsp; perforations&nbsp; occurred&nbsp; in&nbsp; the&nbsp; colonoscopy&nbsp; group,&nbsp; but&nbsp; there&nbsp; were&nbsp; none&nbsp; in&nbsp; the&nbsp; CTC&nbsp; group.&nbsp; A&nbsp; multi-center&nbsp; randomized trial of 1,610 patients assigned to undergo either colonoscopy (n = 1,072) or CTC (n = 538) found an 11% detection rate for cancers and polyps &ge;10 mm with both techniques [48]. A&nbsp; review&nbsp; of&nbsp; a&nbsp; 1-year&nbsp; CTC&nbsp; screening&nbsp; experience&nbsp; for&nbsp; colorectal&nbsp; neoplasia&nbsp; showed&nbsp; that&nbsp; 3.9%&nbsp; of&nbsp; individuals&nbsp; had&nbsp; 1&nbsp; polyp &ge;1&nbsp; cm,&nbsp; and&nbsp; 6.9%&nbsp; had&nbsp; &ge;1&nbsp; polyp(s)&nbsp; 6&nbsp; to&nbsp; 9&nbsp; mm&nbsp; [20].&nbsp; Of&nbsp; the&nbsp; 71&nbsp; patients&nbsp; who&nbsp; chose&nbsp; colonoscopy&nbsp; for&nbsp; further&nbsp; evaluation&nbsp; of&nbsp; these&nbsp; polyps,&nbsp; concordant&nbsp; lesions&nbsp; were&nbsp; found&nbsp; with&nbsp; colonoscopy&nbsp; in&nbsp; 65&nbsp; (91.5%&nbsp; positive&nbsp; predictive&nbsp; value)&nbsp; [20].&nbsp; In&nbsp; addition,&nbsp; the&nbsp; outcomes&nbsp; of&nbsp; patients&nbsp; with&nbsp; negative&nbsp; CTC&nbsp; screens&nbsp; have&nbsp; also&nbsp; been&nbsp; reported.&nbsp; A&nbsp; longitudinal&nbsp; follow-up&nbsp; of&nbsp; 1,011&nbsp; patients&nbsp; over&nbsp; nearly&nbsp; 5&nbsp; years&nbsp; demonstrated&nbsp; a&nbsp; single-interval&nbsp; cancer&nbsp; (crude&nbsp; cancer&nbsp; incidence&nbsp; of&nbsp; 0.2&nbsp; cancers&nbsp; per&nbsp; 1,000&nbsp; patient&nbsp; years),&nbsp; leading&nbsp; to&nbsp; the&nbsp; conclusion&nbsp; that&nbsp; a&nbsp; 5-year&nbsp; routine&nbsp; screen&nbsp; interval&nbsp; and nonreporting of diminutive lesions (&le;5 mm) were appropriate strategies [49]. CTC performance has been evaluated in senior patient cohorts (&ge;65 years of age). A retrospective analysis of 577 subjects found an excellent CTC concordance rate of 91% [50]. Based on a 6-mm threshold, there was an overall patient&nbsp; referral&nbsp; rate&nbsp; of&nbsp; 15%&nbsp; for&nbsp; colonoscopy.&nbsp; Considering&nbsp; only&nbsp; adenomas,&nbsp; the&nbsp; per-patient&nbsp; positivity&nbsp; rates&nbsp; for&nbsp; 6-&nbsp; and&nbsp; 10-mm&nbsp; thresholds&nbsp; were&nbsp; 11%&nbsp; and&nbsp; 7%,&nbsp; respectively.&nbsp; When&nbsp; comparing&nbsp; 204&nbsp; nonsenior&nbsp; (14%)&nbsp; and&nbsp; 250&nbsp; senior&nbsp; patients&nbsp; (13%)&nbsp; undergoing&nbsp; CTC,&nbsp; another&nbsp; study&nbsp; found&nbsp; no&nbsp; statistically&nbsp; significant&nbsp; difference&nbsp; in&nbsp; the&nbsp; percentage&nbsp; of&nbsp; individuals with at least 1 polyp &ge;6 mm [51]. A post hoc analysis of 477 senior patients from the ACRIN National CTC&nbsp; Trial&nbsp; demonstrated&nbsp; that&nbsp; for&nbsp; large&nbsp; neoplasms,&nbsp; sensitivity&nbsp; and&nbsp; specificity&nbsp; among&nbsp; the&nbsp; older&nbsp; cohort&nbsp; were&nbsp; 82%&nbsp; and&nbsp; 83%,&nbsp; respectively&nbsp; [52].&nbsp; There&nbsp; was&nbsp; no &nbsp;statistically&nbsp; significant&nbsp; difference&nbsp; when&nbsp; compared&nbsp; with&nbsp; the&nbsp; sensitivity&nbsp; and&nbsp; specificity&nbsp; of&nbsp; 92%&nbsp; and&nbsp; 86%,&nbsp; respectively,&nbsp; for&nbsp; lesions&nbsp; &ge;10&nbsp; mm&nbsp; in&nbsp; the&nbsp; younger&nbsp; patient&nbsp; cohort.&nbsp; For&nbsp; lesions&nbsp; &gt;6&nbsp; mm,&nbsp; the&nbsp; sensitivity&nbsp; and&nbsp; specificity&nbsp; were&nbsp; 72%&nbsp; and&nbsp; 86%,&nbsp; respectively,&nbsp; for&nbsp; older&nbsp; patients&nbsp; and&nbsp; 81%&nbsp; and&nbsp; 89%,&nbsp; respectively, for younger patients, with no statistically significant difference. Another study reporting outcomes of 1,400 senior patients who underwent CTC found a 15% frequency for referral to colonoscopy at a polyp threshold of 6 mm [53]. Colorectal neoplasia was identified in 9% of patients, and advanced neoplasia was found in 3%. Similar&nbsp; to&nbsp; colonoscopy,&nbsp; evidence&nbsp; supporting&nbsp; serrated&nbsp; polyp&nbsp; detection&nbsp; at&nbsp; CT&nbsp; is&nbsp; emerging.&nbsp; Despite&nbsp; a&nbsp; subtle,&nbsp; flat&nbsp; nature to sessile serrated polyps, these lesions can be detected at CTC likely because of a phenomenon of polyp coating.&nbsp; It&nbsp; appears&nbsp; that&nbsp; the&nbsp; adherent&nbsp; mucin&nbsp; elaborated&nbsp; by&nbsp; these&nbsp; lesions&nbsp; mix&nbsp; with&nbsp; the&nbsp; tagging&nbsp; agents &nbsp;to&nbsp; form&nbsp; a&nbsp; contrast coat. In an observational CTC screening study (n = 8,289), CTC demonstrated a prevalence of 3.1% for serrated lesions &ge;6 mm in size. As seen by the colonoscopy experience, these lesions tended to be large (&gt;10 mm in&nbsp; size),&nbsp; flat,&nbsp; and&nbsp; right&nbsp; sided.&nbsp; The&nbsp; presence&nbsp; of&nbsp; a&nbsp; contrast&nbsp; coat&nbsp; markedly&nbsp; improved&nbsp; lesion&nbsp; detection&nbsp; with&nbsp; an&nbsp; odds&nbsp; ratio of 40.4 (95% CI, 10.1, 161.4) [54]. Noncathartic CTC also has been assessed in recent years and does not perform as well as conventional CTC. In a prospective&nbsp; study&nbsp; of&nbsp; 605&nbsp; adults&nbsp; at&nbsp; average&nbsp; to&nbsp; moderate&nbsp; risk&nbsp; for&nbsp; colon&nbsp; cancer&nbsp; who&nbsp; underwent&nbsp; both&nbsp; laxative-free&nbsp; CTC and colonoscopy, per patient sensitivity and specificity of CTC were 91% and 85% for adenomas &ge;10 mm, 70% and 86% for adenomas &ge;8 mm, and 59% and 88% for adenomas &ge;6 mm [32]. In a prospective study of 564 asymptomatic&nbsp; adults&nbsp; who&nbsp; underwent&nbsp; noncathartic&nbsp; CTC&nbsp; with&nbsp; fecal&nbsp; tagging,&nbsp; the&nbsp; sensitivity,&nbsp; specificity,&nbsp; negative&nbsp; predictive&nbsp; value,&nbsp; and&nbsp; positive&nbsp; predictive&nbsp; value&nbsp; of&nbsp; noncathartic&nbsp; CTC&nbsp; for&nbsp; adenomatous&nbsp; polyps&nbsp; or&nbsp; cancer&nbsp; &ge;6&nbsp; mm&nbsp; were 76%, 92%, 98%, and 38%, respectively [55].</p>
<p>&nbsp;</p>
<p><strong>X-ray barium enema double-contrast &ndash; DCBE</strong></p>
<p>&nbsp;DCBE also requires a preprocedural bowel cleansing preparation. The study is performed by administration of a liquid barium-based contrast agent and air-insufflation of the colon via a tube inserted into the rectum. Images are acquired with the patient in different obliquities and at different table angulations ranging from supine to standing. Performance&nbsp; of&nbsp; DCBE&nbsp; is&nbsp; dependent&nbsp; on&nbsp; optimal&nbsp; patient&nbsp; positioning&nbsp; because&nbsp; patient&nbsp; anatomy&nbsp; varies.&nbsp; The&nbsp;</p>
<p>ACR Appropriateness Criteria&reg;6 Colorectal Cancer Screening perforation&nbsp; rate&nbsp; during&nbsp; DCBE&nbsp; is&nbsp; approximately&nbsp; 1&nbsp; in&nbsp; 25,000&nbsp; [56]&nbsp; as&nbsp; compared&nbsp; to&nbsp; 1&nbsp; in&nbsp; 22,000&nbsp; for&nbsp; CTC&nbsp; and&nbsp; 1&nbsp; in&nbsp; 1,000 for diagnostic colonoscopy [38,39]. The&nbsp; best&nbsp; evidence&nbsp; regarding&nbsp; the&nbsp; performance&nbsp; of&nbsp; DCBE&nbsp; comes&nbsp; from&nbsp; studies&nbsp; in&nbsp; which&nbsp; patients&nbsp; underwent&nbsp; both&nbsp; DCBE&nbsp; and&nbsp; endoscopy.&nbsp; In&nbsp; a&nbsp; prospective&nbsp; trial&nbsp; including&nbsp; 614&nbsp; patients,&nbsp; each &nbsp;of&nbsp; whom&nbsp; underwent&nbsp; DCBE&nbsp; and&nbsp; colonoscopy,&nbsp; per-patient&nbsp; sensitivity&nbsp; and&nbsp; specificity&nbsp; of&nbsp; DCBE&nbsp; were&nbsp; 48%&nbsp; and&nbsp; 90%,&nbsp; respectively,&nbsp; for&nbsp; lesions&nbsp; &ge;10 mm&nbsp; and&nbsp; 41%&nbsp; and&nbsp; 82%&nbsp; for&nbsp; lesions&nbsp; &ge;6&nbsp; mm,&nbsp; respectively&nbsp; [46].&nbsp; In&nbsp; an&nbsp; evaluation&nbsp; of&nbsp; 190&nbsp; patients&nbsp; who&nbsp; underwent&nbsp; DCBE and colonoscopy, overall sensitivity for polyps was 70%, which increased to 80% for polyps &gt;10 mm [57]. In an evaluation of 675 patients who underwent both flexible sigmoidoscopy and DCBE, DCBE missed 35% of polyps 6 to 10 mm and 17% of polyps &gt;11 mm [58]. A&nbsp; retrospective&nbsp; study&nbsp; evaluated&nbsp; the&nbsp; diagnostic&nbsp; yield&nbsp; of&nbsp; DCBE&nbsp; examinations&nbsp; performed&nbsp; for&nbsp; colorectal&nbsp; cancer&nbsp; screening in average-risk individuals &gt;50 years of age [59]. The diagnostic yield was 5.1% for neoplastic lesions &ge;10&nbsp; mm&nbsp; and&nbsp; 6.2%&nbsp; for&nbsp; advanced&nbsp; neoplastic&nbsp; lesions,&nbsp; regardless&nbsp; of&nbsp; size.&nbsp; These&nbsp; diagnostic&nbsp; yields&nbsp; fall&nbsp; within&nbsp; the&nbsp; lower&nbsp; range&nbsp; of&nbsp; those&nbsp; reported&nbsp; for&nbsp; screening&nbsp; colonoscopy&nbsp; (5.0%&nbsp; to&nbsp; 9.5%&nbsp; for&nbsp; colonic&nbsp; neoplasms&nbsp; &ge;10&nbsp; mm&nbsp; [60-62] &nbsp;and 4.6% to 11.7% for advanced colonic neoplasms, regardless of size [60,62,63]). Additional data on the effectiveness of the DCBE for detecting colorectal cancer comes from studies in which the imaging&nbsp; history&nbsp; of&nbsp; patients&nbsp; with&nbsp; colorectal&nbsp; cancer&nbsp; was&nbsp; reviewed.&nbsp; In&nbsp; many&nbsp; of&nbsp; these&nbsp; studies,&nbsp; the&nbsp; risk&nbsp; level&nbsp; of&nbsp; patients&nbsp; undergoing&nbsp; DCBE&nbsp; was&nbsp; not&nbsp; reported.&nbsp; Based&nbsp; on&nbsp; this&nbsp; methodology,&nbsp; the&nbsp; sensitivity&nbsp; of&nbsp; DCBE&nbsp; ranges&nbsp; from&nbsp; 75%&nbsp; to&nbsp; 95%&nbsp; [64-66].&nbsp; This&nbsp; correlates&nbsp; with&nbsp; a&nbsp; large,&nbsp; population-based&nbsp; study&nbsp; that&nbsp; found&nbsp; the&nbsp; overall&nbsp; rate&nbsp; of&nbsp; new&nbsp; or&nbsp; missed cancers following a DCBE was 22% [67]. A&nbsp; meta-analysis&nbsp; comparing&nbsp; the&nbsp; performance&nbsp; of&nbsp; the&nbsp; DCBE&nbsp; with&nbsp; CTC&nbsp; for&nbsp; detecting&nbsp; polyps&nbsp; &ge;6&nbsp; mm&nbsp; included&nbsp; 11&nbsp; studies using DCBE (5,995 patients, 1,548 polyps) and 30 studies using CTC (6,573 patients, 2,348 polyps) [68]. Despite the inclusion of CTC studies with older techniques, statistically lower sensitivity and specificity were still seen for the DCBE compared with CTC.</p>
<p>&nbsp;</p>
<p><strong>SCBE Single-contrast barium enema (SCBE)</strong> studies are performed by administration of liquid barium via a rectal tube. Unlike&nbsp; a&nbsp; DCBE,&nbsp; the&nbsp; colon&nbsp; is&nbsp; not&nbsp; insufflated&nbsp; with&nbsp; air.&nbsp; SCBE&nbsp; studies&nbsp; are&nbsp; generally&nbsp; performed&nbsp; when&nbsp; patients&nbsp; are&nbsp; unable to tolerate a DCBE (eg, patients unable to stand upright) and a CTC cannot be performed. A&nbsp; preponderance&nbsp; of&nbsp; the&nbsp; literature&nbsp; has&nbsp; demonstrated&nbsp; a&nbsp; markedly&nbsp; inferior&nbsp; performance&nbsp; profile&nbsp; for&nbsp; SCBE.&nbsp; A&nbsp; retrospective&nbsp; evaluation&nbsp; of&nbsp; 139&nbsp; patients&nbsp; who&nbsp; underwent&nbsp; barium&nbsp; enema&nbsp; and&nbsp; had&nbsp; 1&nbsp; or&nbsp; more&nbsp; colonic&nbsp; polyps&nbsp; diagnosed endoscopically found sensitivity of SCBE for polyps &lt;1 cm to be 72% and for polyps &ge;1 cm to be 94% [69].&nbsp; In&nbsp; the&nbsp; same&nbsp; study,&nbsp; the&nbsp; sensitivity&nbsp; of&nbsp; DCBE&nbsp; was&nbsp; 88%&nbsp; for&nbsp; polyps&nbsp; &lt;1&nbsp; cm&nbsp; and&nbsp; 96%&nbsp; for&nbsp; polyps&nbsp; &ge;1&nbsp; cm&nbsp; [69].&nbsp; Patient risk level was not reported in this study. A&nbsp; minority&nbsp; of&nbsp; studies&nbsp; have&nbsp; suggested&nbsp; that&nbsp; a&nbsp; SCBE&nbsp; has&nbsp; the&nbsp; potential&nbsp; to&nbsp; be&nbsp; as&nbsp; sensitive&nbsp; as&nbsp; a&nbsp; DCBE&nbsp; for&nbsp; detecting&nbsp; cancer and large polyps. The reported sensitivity for cancer ranges from 82% to 95% [65,66] and is approximately 95% for large polyps [69]. In a retrospective evaluation of individuals diagnosed with colorectal cancer who had undergone a prior DCBE or SCBE, the cancer miss rate was 4.8% for SCBE and 4.7% for DCBE [65]. However, because&nbsp; of&nbsp; the&nbsp; paucity&nbsp; of&nbsp; studies&nbsp; and&nbsp; limitations&nbsp; of&nbsp; the&nbsp; study&nbsp; designs,&nbsp; questions&nbsp; have&nbsp; been&nbsp; raised&nbsp; about&nbsp; the&nbsp; reproducibility of the results, particularly for large polyps.</p>
<p>&nbsp;</p>
<p><strong>MR Colonography Magnetic resonance (MR)</strong></p>
<p>colonography for colorectal cancer screening is generally considered an investigational test&nbsp; in&nbsp; the&nbsp; United&nbsp; States&nbsp; and&nbsp; has&nbsp; not&nbsp; been&nbsp; adequately&nbsp; validated&nbsp; as&nbsp; an&nbsp; acceptable&nbsp; test&nbsp; for&nbsp; colorectal&nbsp; cancer&nbsp; screening.&nbsp; Although&nbsp; high-resolution&nbsp; imaging&nbsp; is&nbsp; possible&nbsp; with&nbsp; MR&nbsp; techniques,&nbsp; acquisition&nbsp; times&nbsp; are&nbsp; longer&nbsp; as&nbsp; compared to CT imaging, leading to a tradeoff between high resolution and long acquisition time (with resultant motion&nbsp; degradation)&nbsp; with&nbsp; currently&nbsp; available&nbsp; technology.&nbsp; Optimal&nbsp; technique&nbsp; is&nbsp; a&nbsp; source&nbsp; of&nbsp; active&nbsp; investigation,&nbsp; and&nbsp; distention&nbsp; of&nbsp; the&nbsp; colon&nbsp; with&nbsp; liquid&nbsp; (a&nbsp; diluted&nbsp; gadolinium&nbsp; solution&nbsp; for&nbsp; &ldquo;bright&nbsp; lumen&rdquo;&nbsp; T1-weighted&nbsp; imaging&nbsp; [70,71]&nbsp; or&nbsp; tap&nbsp; water&nbsp; for&nbsp; &ldquo;dark&nbsp; lumen&rdquo;&nbsp; T1-weighted&nbsp; imaging&nbsp; [72,73]),&nbsp; air&nbsp; insufflation&nbsp; without&nbsp; bowel&nbsp; cleansing&nbsp; [74], and administration of intravenous contrast material have been evaluated [75]. With current techniques, MR colonography does not perform as well as CTC for detection of polyps, especially for&nbsp; small&nbsp; lesions.&nbsp; Fewer&nbsp; published&nbsp; studies&nbsp; are&nbsp; available&nbsp; evaluating&nbsp; MR&nbsp; colonography&nbsp; as&nbsp; compared&nbsp; to&nbsp; CTC,&nbsp; and&nbsp; sample&nbsp; sizes&nbsp; are&nbsp; generally&nbsp; small&nbsp; for&nbsp; MR&nbsp; colonography&nbsp; studies,&nbsp; which&nbsp; remains&nbsp; primarily&nbsp; an&nbsp; investigational&nbsp; technique.&nbsp; In&nbsp; a&nbsp; systematic&nbsp; review&nbsp; of&nbsp; 13&nbsp; prospective&nbsp; studies&nbsp; evaluating&nbsp; MR&nbsp; colonography&nbsp; performance&nbsp; in&nbsp; 1,285</p>
<p>patients,&nbsp; including&nbsp; asymptomatic&nbsp; patients&nbsp; at&nbsp; average&nbsp; risk&nbsp; and&nbsp; symptomatic&nbsp; patients&nbsp; at&nbsp; increased&nbsp; risk,&nbsp; the&nbsp; per-patient sensitivity and specificity for polyps &ge;10 mm were 88% and 99%, respectively [76]. On a per-polyp basis, polyps&nbsp; of&nbsp; &ge;10&nbsp; mm&nbsp; were&nbsp; detected&nbsp; with&nbsp; a&nbsp; sensitivity&nbsp; of&nbsp; 84%.&nbsp; The&nbsp; data&nbsp; were&nbsp; found&nbsp; to&nbsp; be&nbsp; too&nbsp; heterogeneous&nbsp; for&nbsp; diminutive polyps &lt;6 mm and for small polyps measuring 6 to 9 mm. In&nbsp; a&nbsp; study&nbsp; of&nbsp; 286&nbsp; asymptomatic&nbsp; individuals&nbsp; who&nbsp; underwent&nbsp; both&nbsp; 3T&nbsp; MR&nbsp; colonography&nbsp; and&nbsp; colonoscopy&nbsp; on&nbsp; the&nbsp; same day, sensitivity and specificity of MR colonography for adenomas &ge;6 mm were 78% and 95%, respectively [77]. In an evaluation of 46 patients (screening and asymptomatic) who underwent MR colonography followed by colonoscopy,&nbsp; MR&nbsp; colonography&nbsp; was&nbsp; 67%&nbsp; sensitive&nbsp; and&nbsp; 96%&nbsp; specific&nbsp; for&nbsp; polyp&nbsp; detection &nbsp;on&nbsp; a&nbsp; per-patient&nbsp; basis&nbsp; [75] and was 100% sensitive (4/4) and 100% specific (20/20) for lesions 6 to 9 mm [75]. In a smaller pilot study of&nbsp; 29&nbsp; patients&nbsp; who&nbsp; underwent&nbsp; both&nbsp; MR&nbsp; colonography&nbsp; performed&nbsp; with&nbsp; barium&nbsp; fecal&nbsp; tagging&nbsp; and&nbsp; air&nbsp; distention&nbsp; followed&nbsp; by&nbsp; colonoscopy,&nbsp; for&nbsp; &ge;10-mm&nbsp; lesions,&nbsp; the&nbsp; sensitivity&nbsp; and&nbsp; specificity&nbsp; of&nbsp; MR&nbsp; colonography&nbsp; were&nbsp; 44&nbsp; and&nbsp; 100%, respectively. However, for 5- to 9-mm lesions, specificity was 95% but sensitivity was only 6% [74]. The risk level of patients was not reported</p>
<p><strong>References</strong></p>
<ol>
    <li>Akinosoglou K, Apostolakis E, Marangos M, Pasvol G. Native valve right sided infective endocarditis. Eur J Intern Med2013;24:510-9.</li>
    <li>Cecchi E,&nbsp; Imazio&nbsp; M,&nbsp; Tidu&nbsp; M,&nbsp; et&nbsp; al.&nbsp; Infective&nbsp; endocarditis&nbsp; in&nbsp; drug&nbsp; addicts:&nbsp; role&nbsp; of&nbsp; HIV&nbsp; infection&nbsp; and&nbsp; the&nbsp; diagnostic accuracy of Duke criteria. J Cardiovasc Med (Hagerstown)2007;8:169-75.</li>
    <li>Lee MR, Chang SA, Choi SH, et al. Clinical features of right-sided infective endocarditis occurring in non-drug users. J Korean Med Sci2014;29:776-81.</li>
    <li>Erba PA, Pizzi MN, Roque A, et al. Multimodality Imaging in Infective Endocarditis: An Imaging Team Within the Endocarditis Team. Circulation2019;140:1753-65.</li>
    <li>Haldar SM,&nbsp; O'Gara&nbsp; PT.&nbsp; Infective&nbsp; endocarditis:&nbsp; diagnosis&nbsp; and&nbsp; management.&nbsp; Nat&nbsp; Clin&nbsp; Pract&nbsp; Cardiovasc&nbsp; Med2006;3:310-7.</li>
    <li>Kiefer TL,&nbsp;&nbsp; Bashore&nbsp;&nbsp; TM.&nbsp;&nbsp; Infective&nbsp;&nbsp; endocarditis:&nbsp;&nbsp; a&nbsp;&nbsp; comprehensive&nbsp;&nbsp; overview.&nbsp;&nbsp; Rev&nbsp;&nbsp; Cardiovasc&nbsp;&nbsp; Med2012;13:e105-20.</li>
    <li>Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by:&nbsp; European&nbsp; Association&nbsp; for&nbsp; Cardio-Thoracic&nbsp; Surgery&nbsp; (EACTS),&nbsp; the&nbsp; European&nbsp; Association&nbsp; of&nbsp; Nuclear Medicine (EANM). Eur Heart J2015;36:3075-128.</li>
    <li>Anguera I, Miro JM, Evangelista A, et al. Periannular complications in infective endocarditis involving native aortic valves. Am J Cardiol2006;98:1254-60.</li>
    <li>Anguera I,&nbsp; Miro&nbsp; JM,&nbsp; San&nbsp; Roman&nbsp; JA,&nbsp; et&nbsp; al.&nbsp; Periannular&nbsp; complications&nbsp; in&nbsp; infective&nbsp; endocarditis&nbsp; involving&nbsp; prosthetic aortic valves. Am J Cardiol2006;98:1261-8.</li>
    <li>Gomes A, Glaudemans A, Touw DJ, et al. Diagnostic value of imaging in infective endocarditis: a systematic review. Lancet Infect Dis2017;17:e1-e14.</li>
    <li>American College&nbsp; of&nbsp; Radiology.&nbsp; ACR&ndash;NASCI&ndash;SIR&ndash;SPR&nbsp; Practice&nbsp; Parameter&nbsp; for &nbsp;the&nbsp; Performance&nbsp; and&nbsp; Interpretation&nbsp; of&nbsp; Body&nbsp; Computed&nbsp; Tomography&nbsp; Angiography&nbsp; (CTA).&nbsp; Available&nbsp; at:&nbsp; https://www.acr.org/-/media/ACR/Files/Practice-Parameters/body-cta.pdf. Accessed September 30, 2020.</li>
    <li>Kung VW, Jarral OA, Shipolini AR, McCormack DJ. Is it safe to perform coronary angiography during acute endocarditis? Interact Cardiovasc Thorac Surg2011;13:158-67.</li>
    <li>Bruun NE, Habib G, Thuny F, Sogaard P. Cardiac imaging in infectious endocarditis. Eur Heart J2014;35:624-32.</li>
    <li>Colen TW, Gunn M, Cook E, Dubinsky T. Radiologic manifestations of extra-cardiac complications of infective endocarditis. Eur Radiol2008;18:2433-45.</li>
    <li>Fagman E, Flinck A, Snygg-Martin U, Olaison L, Bech-Hanssen O, Svensson G. Surgical decision-making in aortic prosthetic&nbsp; valve&nbsp; endocarditis:&nbsp; the&nbsp; influence&nbsp; of&nbsp; electrocardiogram-gated&nbsp; computed&nbsp; tomography.&nbsp; Eur&nbsp; J&nbsp; Cardiothorac Surg2016;50:1165-71.</li>
    <li>Fagman E, Perrotta S, Bech-Hanssen O, et al. ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis. Eur Radiol2012;22:2407-14.</li>
    <li>Feuchtner GM,&nbsp; Stolzmann&nbsp; P,&nbsp; Dichtl&nbsp; W,&nbsp; et&nbsp; al.&nbsp; Multislice&nbsp; computed&nbsp; tomography&nbsp; in&nbsp; infective&nbsp; endocarditis:&nbsp; comparison&nbsp;&nbsp; with&nbsp;&nbsp; transesophageal&nbsp;&nbsp; echocardiography&nbsp;&nbsp; and&nbsp;&nbsp; intraoperative&nbsp;&nbsp; findings.&nbsp;&nbsp; J&nbsp;&nbsp; Am&nbsp;&nbsp; Coll&nbsp;&nbsp; Cardiol2009;53:436-44.</li>
    <li>Gahide G, Bommart S, Demaria R, et al. Preoperative evaluation in aortic endocarditis: findings on cardiac CT. AJR2010;194:574-8.</li>
    <li>Koo HJ, Yang DH, Kang JW, et al. Demonstration of infective endocarditis by cardiac CT and transoesophageal echocardiography: comparison&nbsp; with&nbsp; intra-operative&nbsp; findings.&nbsp; Eur&nbsp; Heart&nbsp; J&nbsp; Cardiovasc&nbsp; Imaging2018;19:199-207.</li>
    <li>Kim IC,&nbsp; Chang&nbsp; S,&nbsp; Hong&nbsp; GR,&nbsp; et&nbsp; al.&nbsp; Comparison&nbsp; of&nbsp; Cardiac&nbsp; Computed&nbsp; Tomography&nbsp; With&nbsp; Transesophageal&nbsp; Echocardiography&nbsp; for&nbsp; Identifying&nbsp; Vegetation&nbsp; and&nbsp; Intracardiac&nbsp; Complications&nbsp; in&nbsp; Patients&nbsp; With&nbsp; Infective&nbsp; Endocarditis in the Era of 3-Dimensional Images. Circ Cardiovasc Imaging2018;11:e006986.</li>
    <li>Cahill TJ, Baddour LM, Habib G, et al. Challenges in Infective Endocarditis. J Am Coll Cardiol2017;69:325-44.</li>
    <li>Habets J, Tanis W, van Herwerden LA, et al. Cardiac computed tomography angiography results in diagnostic and therapeutic change in prosthetic heart valve endocarditis. Int J Cardiovasc Imaging2014;30:377-87.</li>
    <li>Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol2014;63:2438-88.</li>
    <li>Symersky P, Budde RP, de Mol BA, Prokop M. Comparison of multidetector-row computed tomography to echocardiography and fluoroscopy for evaluation of patients with mechanical prosthetic valve obstruction. Am J Cardiol2009;104:1128-34.</li>
    <li>Akhtar NJ, Markowitz AH, Gilkeson RC. Multidetector computed tomography in the preoperative assessment of cardiac surgery patients. Radiol Clin North Am2010;48:117-39.</li>
    <li>Rybicki FJ, Sheth T, Chen FY. Cardiac Surgical Imaging. In: Cohn L, ed. Cardiac Surgery in the Adult. 3 rd ed. New York: McGraw-Hill; 2008:179-98.</li>
    <li>Fairbairn TA, Nieman K, Akasaka T, et al. Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE Registry. Eur Heart J2018;39:3701-11.</li>
    <li>Collet C, Onuma Y, Andreini D, et al. Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease. Eur Heart J2018;39:3689-98.</li>
    <li>Kouijzer IJ, Vos FJ, Janssen MJ, van Dijk AP, Oyen WJ, Bleeker-Rovers CP. The value of 18F-FDG PET/CT in diagnosing infectious endocarditis. Eur J Nucl Med Mol Imaging2013;40:1102-7.</li>
    <li>Ricciardi A, Sordillo P, Ceccarelli L, et al. 18-Fluoro-2-deoxyglucose positron emission tomography-computed tomography: an additional tool in the diagnosis of prosthetic valve endocarditis. Int J Infect Dis2014;28:219-24.</li>
    <li>Swart LE, Gomes A, Scholtens AM, et al. Improving the Diagnostic Performance of (18)F-Fluorodeoxyglucose Positron-Emission Tomography/Computed&nbsp; Tomography&nbsp; in&nbsp; Prosthetic&nbsp; Heart&nbsp; Valve&nbsp; Endocarditis.&nbsp; Circulation2018;138:1412-27.</li>
    <li>Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis:&nbsp; increased&nbsp; valvular 18F-fluorodeoxyglucose&nbsp; uptake&nbsp; as&nbsp; a&nbsp; novel&nbsp; major&nbsp; criterion.&nbsp; J&nbsp; Am&nbsp; Coll&nbsp; Cardiol2013;61:2374-82.</li>
    <li>Graziosi M, Nanni C, Lorenzini M, et al. Role of (1)(8)F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study. Eur J Nucl Med Mol Imaging2014;41:1617-23.</li>
    <li>Pizzi MN,&nbsp; Dos-Subira&nbsp; L,&nbsp; Roque&nbsp; A,&nbsp; et&nbsp; al.&nbsp; (18)F-FDG-PET/CT&nbsp; angiography&nbsp; in&nbsp; the&nbsp; diagnosis&nbsp; of&nbsp; infective&nbsp; endocarditis and cardiac device infection in adult patients with congenital heart disease and prosthetic material. Int J Cardiol2017;248:396-402.</li>
    <li>Horstkotte D,&nbsp; Korfer&nbsp; R,&nbsp; Loogen&nbsp; F,&nbsp; Rosin&nbsp; H,&nbsp; Bircks&nbsp; W.&nbsp; Prosthetic&nbsp; valve&nbsp; endocarditis:&nbsp; clinical&nbsp; findings&nbsp; and&nbsp; management. Eur Heart J1984;5 Suppl C:117-22.</li>
    <li>Tsopelas C.&nbsp;&nbsp;&nbsp; Radiotracers&nbsp;&nbsp;&nbsp; used&nbsp;&nbsp;&nbsp; for&nbsp;&nbsp;&nbsp; the&nbsp;&nbsp;&nbsp; scintigraphic&nbsp;&nbsp;&nbsp; detection&nbsp;&nbsp;&nbsp; of&nbsp;&nbsp;&nbsp; infection&nbsp;&nbsp;&nbsp; and&nbsp;&nbsp;&nbsp; inflammation.&nbsp;&nbsp;&nbsp; ScientificWorldJournal2015;2015:676719.</li>
    <li>McDermott BP, Mohan S, Thermidor M, Parchuri S, Poulose J, Cunha BA. The lack of diagnostic value of the indium scan in acute bacterial endocarditis. Am J Med2004;117:621-3.</li>
    <li>Dursun M,&nbsp; Yilmaz&nbsp; S,&nbsp; Yilmaz&nbsp; E,&nbsp; et&nbsp; al.&nbsp; The&nbsp; utility&nbsp; of&nbsp; cardiac&nbsp; MRI&nbsp; in&nbsp; diagnosis&nbsp; of&nbsp; infective&nbsp; endocarditis:&nbsp; preliminary results. Diagn Interv Radiol2015;21:28-33.</li>
    <li>Baddour LM, Wilson WR, Bayer AS, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation2015;132:1435-86.</li>
    <li>Habib G, Badano L, Tribouilloy C, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr2010;11:202-19.</li>
    <li>Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med1994;96:200-9.</li>
    <li>Aly AM, Simpson PM, Humes RA. The role of transthoracic echocardiography in the diagnosis of infective endocarditis in children. Arch Pediatr Adolesc Med1999;153:950-4.</li>
    <li>Harris KM, Li DY, L'Ecuyer P, et al. The prospective role of transesophageal echocardiography in the diagnosis and management of patients with suspected infective endocarditis. Echocardiography2003;20:57-62.</li>
    <li>San Roman JA, Vilacosta I, Lopez J, et al. Role of transthoracic and transesophageal echocardiography in right-sided endocarditis: one echocardiographic modality does not fit all. J Am Soc Echocardiogr2012;25:807-14.</li>
    <li>Lauridsen TK, Park L, Tong SY, et al. Echocardiographic Findings Predict In-Hospital and 1-Year Mortality in Left-Sided Native Valve Staphylococcus aureus Endocarditis: Analysis From the International Collaboration on Endocarditis-Prospective Echo Cohort Study. Circ Cardiovasc Imaging2015;8:e003397.</li>
    <li>Sivak JA,&nbsp; Vora&nbsp; AN,&nbsp; Navar&nbsp; AM,&nbsp; et&nbsp; al.&nbsp; An&nbsp; Approach&nbsp; to&nbsp; Improve&nbsp; the&nbsp; Negative&nbsp; Predictive&nbsp; Value&nbsp; and&nbsp; Clinical&nbsp; Utility&nbsp; of&nbsp; Transthoracic&nbsp; Echocardiography&nbsp; in&nbsp; Suspected&nbsp; Native&nbsp; Valve&nbsp; Infective&nbsp; Endocarditis.&nbsp; J&nbsp; Am&nbsp; Soc&nbsp; Echocardiogr2016;29:315-22.</li>
    <li>Hill EE,&nbsp; Herijgers&nbsp; P,&nbsp; Claus&nbsp; P,&nbsp; Vanderschueren&nbsp; S,&nbsp; Peetermans&nbsp; WE,&nbsp; Herregods&nbsp; MC.&nbsp; Abscess&nbsp; in&nbsp; infective&nbsp; endocarditis:&nbsp; the&nbsp; value&nbsp; of&nbsp; transesophageal&nbsp; echocardiography&nbsp; and&nbsp; outcome:&nbsp; a&nbsp; 5-year&nbsp; study.&nbsp; Am&nbsp; Heart&nbsp; J2007;154:923-8.</li>
    <li>Incani A, Hair C, Purnell P, et al. Staphylococcus aureus bacteraemia: evaluation of the role of transoesophageal echocardiography in&nbsp; identifying&nbsp; clinically&nbsp; unsuspected&nbsp; endocarditis.&nbsp; Eur&nbsp; J&nbsp; Clin&nbsp; Microbiol&nbsp; Infect&nbsp; Dis2013;32:1003-8.</li>
    <li>Law A, Honos G, Huynh T. Negative predictive value of multiplane transesophageal echocardiography in the diagnosis of infective endocarditis. Eur J Echocardiogr2004;5:416-21.</li>
    <li>Hubert S,&nbsp; Thuny&nbsp; F,&nbsp; Resseguier&nbsp; N,&nbsp; et&nbsp; al.&nbsp; Prediction&nbsp; of&nbsp; symptomatic&nbsp; embolism&nbsp; in&nbsp; infective&nbsp; endocarditis:&nbsp; construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol2013;62:1384-92.</li>
    <li>Koneru S, Huang SS, Oldan J, et al. Role of preoperative cardiac CT in the evaluation of infective endocarditis: comparison with transesophageal echocardiography and surgical findings. Cardiovasc Diagn Ther2018;8:439-49.</li>
    <li>Bonfiglioli R,&nbsp; Nanni&nbsp; C,&nbsp; Morigi&nbsp; JJ,&nbsp; et&nbsp; al.&nbsp; (1)(8)F-FDG&nbsp; PET/CT&nbsp; diagnosis&nbsp; of&nbsp; unexpected&nbsp; extracardiac&nbsp; septic&nbsp; embolisms in patients with suspected cardiac endocarditis. Eur J Nucl Med Mol Imaging2013;40:1190-6.</li>
    <li>Bensimhon L,&nbsp; Lavergne&nbsp; T,&nbsp; Hugonnet&nbsp; F,&nbsp; et&nbsp; al.&nbsp; Whole&nbsp; body&nbsp; [(18)&nbsp; F]fluorodeoxyglucose&nbsp; positron&nbsp; emission&nbsp; tomography&nbsp; imaging&nbsp; for&nbsp; the&nbsp; diagnosis&nbsp; of&nbsp; pacemaker&nbsp; or&nbsp; implantable&nbsp; cardioverter&nbsp; defibrillator&nbsp; infection:&nbsp; a&nbsp; preliminary prospective study. Clin Microbiol Infect2011;17:836-44.</li>
    <li>Ploux S, Riviere A, Amraoui S, et al. Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm2011;8:1478-81.</li>
    <li>Sarrazin JF, Philippon F, Tessier M, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for&nbsp; identification&nbsp; of&nbsp; cardiovascular&nbsp; implantable&nbsp; electronic&nbsp; device&nbsp; infections.&nbsp; J&nbsp; Am&nbsp; Coll&nbsp; Cardiol2012;59:1616-25.</li>
    <li>Vind SH, Hess S. Possible role of PET/CT in infective endocarditis. J Nucl Cardiol2010;17:516-9.</li>
    <li>Yen RF,&nbsp; Chen&nbsp; YC,&nbsp; Wu&nbsp; YW,&nbsp; Pan&nbsp; MH,&nbsp; Chang&nbsp; SC.&nbsp; Using&nbsp; 18-fluoro-2-deoxyglucose&nbsp; positron&nbsp; emission&nbsp; tomography in detecting infectious endocarditis/endoarteritis: a preliminary report. Acad Radiol2004;11:316-21.</li>
    <li>Hyafil F, Rouzet F, Lepage L, et al. Role of radiolabelled leucocyte scintigraphy in patients with a suspicion of prosthetic valve&nbsp;&nbsp; endocarditis&nbsp;&nbsp; and&nbsp;&nbsp; inconclusive&nbsp;&nbsp; echocardiography.&nbsp;&nbsp; Eur&nbsp;&nbsp; Heart&nbsp;&nbsp; J&nbsp;&nbsp; Cardiovasc&nbsp;&nbsp; Imaging2013;14:586-94.</li>
    <li>Rouzet F, Chequer R, Benali K, et al. Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. J Nucl Med2014;55:1980-5.</li>
    <li>Harris KM, Ang E, Lesser JR, Sonnesyn SW. Cardiac magnetic resonance imaging for detection of an abscess associated with prosthetic valve endocarditis: a case report. Heart Surg Forum2007;10:E186-7.</li>
    <li>Wong D,&nbsp; Rubinshtein&nbsp; R,&nbsp; Keynan&nbsp; Y.&nbsp; Alternative&nbsp; Cardiac&nbsp; Imaging&nbsp; Modalities&nbsp; to&nbsp; Echocardiography&nbsp; for&nbsp; the&nbsp; Diagnosis of Infective Endocarditis. Am J Cardiol2016;118:1410-18.</li>
    <li>Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr2017;30:303-71.</li>
    <li>Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation2005;112:69-75.</li>
    <li>Vieira ML, Grinberg M, Pomerantzeff PM, Andrade JL, Mansur AJ. Repeated echocardiographic examinations of patients with suspected infective endocarditis. Heart2004;90:1020-4.</li>
    <li>American College&nbsp; of&nbsp; Radiology.&nbsp; ACR&nbsp; Appropriateness&nbsp; Criteria&reg;&nbsp; Radiation&nbsp; Dose&nbsp; Assessment&nbsp; Introduction.&nbsp; Available&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; at:https://www.acr.org/-/media/ACR/Files/Appropriateness-Criteria/RadiationDoseAssessmentIntro.pdf. Accessed September 30, 2020</li>
</ol></body>
</html>